Menu Search
Equities

Omda AS

OMDA:OSL

Omda AS

Actions
Health CareHealth Care Providers
  • Price (NOK)32.00
  • Today's Change-3.10 / -8.83%
  • Shares traded15.50k
  • 1 Year change-1.54%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy1
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in NOK

The 2 analysts offering 12 month price targets for Omda AS have a median target of 44.50, with a high estimate of 49.00 and a low estimate of 40.00. The median estimate represents a 39.06% increase from the last price of 32.00.
High53.1%49.00
Med39.1%44.50
Low25.0%40.00

Earnings history & estimates in NOK

On May 13, 2024, losses of -0.65 per share.
The next earnings announcement is expected on Nov 08, 2024.
Average growth rate-95.52%
Omda AS reported annual 2023 earnings of 4.98 per share on Mar 01, 2024.
Average growth rate-456.93%
More ▼

Revenue history & estimates in NOK

Omda AS had 2nd quarter 2024 revenues of 104.17m. This missed the 112.00m consensus estimate of the 2 analysts following the company. This was 2.33% above the prior year's 2nd quarter results.
Average growth rate+0.32%
Omda AS had revenues for the full year 2023 of 415.07m. This was 12.29% above the prior year's results.
Average growth rate+22.65%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.